Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

WOCKHARDT LTD.

NSE : WOCKPHARMABSE : 532300ISIN CODE : INE049B01025Industry : Pharmaceuticals & DrugsHouse : Wockhardt
BSE1960.9080.65 (+4.29 %)
PREV CLOSE () 1880.25
OPEN PRICE () 1892.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 58373
TODAY'S LOW / HIGH ()1872.30 1987.55
52 WK LOW / HIGH ()1086.8 2420
NSE1962.0079.9 (+4.25 %)
PREV CLOSE() 1882.10
OPEN PRICE () 1883.10
BID PRICE (QTY) 1962.00 (188)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1210241
TODAY'S LOW / HIGH() 1874.00 1987.00
52 WK LOW / HIGH ()1086.7 2422.3
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1999

Management Info :

Habil Khorakiwala - Chairman Murtaza Khorakiwala - Managing Director

Registered Office :

Address : D-4, M. I. D. C,Chikalthana, ,
Chhatrapati Sambhajinagar - (Aurangabad),
Maharashtra-431006

Phone : 0240-6632222 / 6694444

Website : www.wockhardt.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
10Jul Wockhardt informs about certificate
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Reg..
01Jun Wockhardt shines on securing USFDA’s a
Wockhardt is currently trading at Rs. 2166.05, up by 135.35 points or 6...
01Jun Wockhardt secures USFDA’s approval for
Wockhardt has secured U.S. Food and Drug Administration’s (USFDA) approv..
28May Wockhardt gets CDSCO’s nod to import,
Wockhardt has secured Central Drugs Standard Control Organisation’s (CDS..
04May Wockhardt informs about press release
Pursuant to Regulation 30 of the Listing Regulations, Wockhardt has encl..
Financials
in Millions
QTR Jun 26 ANNUAL 26
Net Profit10703170
Gross Profit 1070 3170
Operating Profit 19106540
Net Sales 561017390
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Torrent Pharma (BSE)
 5025.00 (2.80%)
M.Cap ( in Cr)
191134.85
Acutaas Chemicals (BSE)
 3332.55 (2.16%)
M.Cap ( in Cr)
27283.96
Zydus Lifesciences (BSE)
 1189.00 (3.58%)
M.Cap ( in Cr)
118603.21
Glaxosmithkline Phar (BSE)
 3068.35 (1.35%)
M.Cap ( in Cr)
51979.70
Shilpa Medicare (BSE)
 900.10 (4.65%)
M.Cap ( in Cr)
17604.32
Shareholding Pattern
PROMOTERS 49.08%
NON-INSTITUTION 34.45%
MUTUAL FUNDS/UTI 6.79%
FI/BANKS/INSURANCE 0.21%
GOVERNMENT 0.02%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX76933.59-539.35 (-0.70%)
NIFTY24090.85-116.90 (-0.48%)
Dow Jones 53569.44105.56 (0.20%)
Nasdaq 26541.35411.15 (1.57%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI